Genemod AI
Resources
Engineering T-cells to treat cancer in a new way

Engineering T Cells to Treat Cancer in a New Way

CAR-T therapy is an FDA approved immunotherapy using a patient’s own modified T-cells to target, kill and reduce the recurrence of cancer cells in some patients.

Chimeric Antigen Receptor T Cells (CAR-T Cells) are part of the body’s immune system that has been altered to fight cancer. T cells are taken from a patient then genetically engineered to put CARs on the surface of the cells before multiplying the cells in the lab. After freezing, shipping, and thawing, they are reintroduced into the patient’s bloodstream. This process is called immunotherapy or, specifically, CAR-T therapy.

Types of Cancer Treated

One of the emerging adoptive cell transfer (ACT) immunotherapies, CAR-T therapy has been clinically developed more extensively than TILs or TCRs. These cells are considered a living drug that may also prevent reoccurrence of cancers like some adult lymphomas and acute lymphoblastic leukemia in children and young adults.

FDA Approved Treatments

CAR-T therapy is FDA approved in the following trademarks:

  • Tisagenlecleucel - Trademarked Kymriah
  • Axicabtagene ciloleucel – Trademarked Yescarta
  • Tocilizumab – Trademarked Actemra

Tisagenlecleucel has been approved for patients up to 25 years old with some cases of acute lymphoblastic leukemia. Axicabtagene ciloleucel is approved for adults with certain large B-cell lymphomas. In young children two and older up to adults, Tocilizumab is approved to treat cytokine release syndrome (CRS) induced by CAR-T cells.

Possible Side Effects

While potentially life-saving, there are also side effects to treatment using CAR-T cells.

  • Cytokine release syndrome produces flu-like symptoms
  • Neurologic events like brain disease or injury, confusion and seizures
  • Low white blood cells (neutropenia)
  • Low red blood cells (anemia)

Most of these side effects can be treated with pharmaceuticals or can be allowed to abate on their own. However, the benefits can far outweigh potential side effects when the disease being treated is life-threatening.

Genemod is a user-friendly software that allows researchers to get up and running quickly with little learning curve. For more information on how their software can help with sequence editing, digest mapping and more, contact Genemod for a demo.

Top 10 SciSpot Alternatives: More Operational LIMS Platforms to Watch in 2026

Looking for SciSpot alternatives in 2026? Discover why labs outgrow ELN-first platforms and why Genemod is the strongest operational LIMS for scaling R&D teams.
January 16, 2026

Why Do Labs Keep Losing Track of Samples After They Scale?

As labs scale, samples don’t disappear—they become untraceable. Discover why sample tracking breaks down after growth and how a modern LIMS like Genemod prevents operational drift.
January 12, 2026

Top 10 Biotech Companies in San Diego to Watch Leading Into 2026

San Diego remains a global biotech hub. Explore 10 San Diego-headquartered biotech companies to watch leading into 2026, spanning genomics, rare disease therapeutics, oncology, and platform innovation.
January 21, 2026
Read more blogs